InvestorsHub Logo
Followers 46
Posts 6373
Boards Moderated 0
Alias Born 06/17/2009

Re: None

Thursday, 08/17/2023 7:49:36 PM

Thursday, August 17, 2023 7:49:36 PM

Post# of 470833

Vaxxinity Alzheimer’s treatment shows promising results in early trial



Jeffrey Cummings, an Anavex SAB member, is quoted.

https://www.biopharma-reporter.com/Article/2023/08/15/vaxxinity-alzheimer-s-treatment-shows-promising-results-in-early-trial
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News